Termination of a partial hydatidiform mole and coexisting fetus: A case report

Table 1 Previously reported cases of PHMCF during the second trimester in the literature

Time of pregnancy termination	β-HCG before termination (IU / L)	Methods for pregnancy termination	Live fetus	Persistent trophoblastic disease	Metastasis	IVF-ET	Ref.
17 wk	449078	Rivanol and aspiration curettage	No	Yes	Lung metastasis	No	[18]
16 wk	800842	Rivanol	No	Yes	Lung metastasis	Yes	[15]
14 wk	229000	Misoprostol	No	Yes	Lung metastasis	Yes	[19]
15 wk	270000	Suction curettage	No	Yes	No	No	[8]
20 wk	878000	Suction curettage	No	No	No	No	[8]
27 wk	Unknown	Spontaneous abortion	No	Yes	Lung metastasis	No	[22]
21 wk	1100000	Spontaneous abortion	No	Yes	No	No	[23]
23 wk	133100	Spontaneous abortion	No	No	No	No	[24]
15 wk	600000	Hysterectomy	No	Yes	No	No	[16]
27 wk	Unknown	Cesarean section	No	No	No	No	[20]
23 wk	76642	Cesarean section	No	No	No	No	[21]
23 wk	510427	Cesarean section	No	No	No	Yes	Present

PHMCF: Partial hydatidiform mole and coexisting fetus; IVF-ET: In vitro fertilization and embryo transfer.